Efficacy and Safety of Vildagliptin as add-on Therapy to Insulin in Patients With Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

448

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Vildagliptin

DRUG

Placebo

Trial Locations (66)

Unknown

Novartis Investigative Site, Box Hill

Novartis Investigative Site, Heidelberg Heights

Novartis Investigative Site, Parkville

Novartis Investigative Site #1, Wollongong

Novartis Investigative Site #2, Wollongong

Novartis Investigative Site, Bonheiden

Novartis Investigative Site, Edegem

Novartis Investigative Site, Genk

Novartis Investigative Site, La Louvière

Novartis Investigative Site, Ronse

Novartis Investigative Site #1, Ostrava

Novartis Investigative Site #2, Ostrava

Novartis Investigative Site #3, Ostrava

Novartis Investigative Site, Aßlar

Novartis Investigative Site, Bensheim

Novartis Investigative Site, Berlin

Novartis Investigative Site, Einbeck

Novartis Investigative Site #1, Hamburg

Novartis Investigative Site #2, Hamburg

Novartis Investigative Site #3, Hamburg

Novartis Investigative Site #4, Hamburg

Novartis Investigative Site, Hanover

Novartis Investigative Site #1, Kassel

Novartis Investigative Site #2, Kassel

Novartis Investigative Site, München

Novartis Investigative Site, Saarlouis

Novartis Investigative Site, Schliemannstadt Neubukow

Novartis Investigative Site, Tübingen

Novartis Investigative Site #1, Guatemala City

Novartis Investigative Site #2, Guatemala City

Novartis Investigative Site #3, Guatemala City

Novartis Investigative Site #4, Guatemala City

Novartis Investigative Site #5, Guatemala City

Novartis Investigative Site #1, Hong Kong

Novartis Investigative Site #2, Hong Kong

Novartis Investigative Site #1, Budapest

Novartis Investigative Site #2, Budapest

Novartis Investigative Site, Dunaújváros

Novartis Investigative Site, Nyíregyháza

Novartis Investigative Site, Szeged

Novartis Investigative Site, Indore

Novartis Investigative Site, Jaipur

Novartis Investigative Site, Karnāl

Novartis Investigative Site #2, Mumbai

Novartis Investigative Site #1, Mumbia

Novartis Investigative Site #1, Nagpur

Novartis Investigative Site #2, Nagpur

Novartis Investigative Site, Nashik

Novartis Investigative Site #1, Trivandrum

Novartis Investigative Site #2, Trivandrum

Novartis Investigative Site, Alba Iulia

Novartis Investigative Site, Bucharest

Novartis Investigative Site #1, Oradea

Novartis Investigative Site #2, Oradea

Novartis Investigative Site, Târgu Mureş

Novartis Investigative Site, Banská Bystrica

Novartis Investigative Site #1, Bratislava

Novartis Investigative Site #2, Bratislava

Novartis Investigative Site #3, Bratislava

Novartis Investigative Site #1, Košice

Novartis Investigative Site #2, Košice

Novartis Investigative Site, Prešov

Novartis Investigative Site, Štúrovo

Novartis Investigative Site, Carmarthen

Novartis Investigative Site #1, Glasgow

Novartis Investigative Site #2, Glasgow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY